// App-Quantinova.ai

15344 : Outcomes of the Hybrid Convergent Procedure Compared to Catheter Ablation Stratified by Anti-arrhythmic Drug Usage: Results From Converge Ide, Prospective, Randomized, Multi-center Trial

Researchers

Presenter

  • David De Lurgio

Principal Investigators

  • Karl J Crossen

  • Jaswinder S Gill

  • Christopher Blauth

  • Saumil Oza

  • Anthony Magnano

  • Faraz Kerendi

  • David Tschopp

  • Tyler Taigen

  • Hugh G Calkins

Medical Centers

  • Emory Health Care, Atlanta, GA

  • Tupelo, MS

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Loyola University Chicago, Maywood, IL

  • Ponte Vedra Beach, FL

  • CARDIOTHORACIC & VASCULAR SURGEONS, Austin, TX

  • Texas Cardiac Arrhythmia, Austin, TX

  • Summa Health Care, Northeast Ohio Cardiovascular Specialist, Shaker Heights, OH

  • JOHNS HOPKINS UNIVERSITY SOM, Baltimore, MD

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved